Pharmacology Watch – August 1, 2017
August 1, 2017
View Issues
-
New PPI Mortality Data: Is There a Risk?
Are proton pump inhibitors associated with excess risk of mortality? That is the finding of a highly publicized study.
-
Antibiotics for Upper Respiratory Infections in Elderly Patients
Physicians who were more likely to prescribe an antibiotic for an acute upper respiratory tract infection included mid- and late-career physicians, physicians trained outside of Canada or the United States, and high-volume physicians.
-
Investigators Tackle Antimicrobial Resistance
Researchers suggested that “modified use of antimicrobial agents and public health interventions, coupled with novel antimicrobial strategies, may help mitigate the effect of multidrug-resistant organisms in the future.”
-
Exploring the Rising Prices of Generic Drugs
Study: As competition among generic drugs decreases, prices go up.
-
Comparing Insulin Treatments for Diabetic Patients
Authors of two studies suggested that 32 weeks’ treatment with insulin degludec vs. insulin glargine U100 resulted in a reduced rate of overall symptomatic hypoglycemic episodes.
-
FDA Actions
In this section: New FDA commissioner off to fast start on opioids, drug safety, and orphan drug designation.